Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029)

Clinical trial NCT01286207 · COMPLETED

Trial details

NCT number: NCT01286207
Sponsor: Organon and Co
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 1995-03-01
Primary completion: 1997-05-01
Enrollment: 1959

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.